A randomized controlled trial of botulinum toxin A for treating neuropathic pain in patients with spinal cord injury: Retraction
ثبت نشده
چکیده
[1] The article, “A randomized controlled trial of botulinum toxin A for treating neuropathic pain in patients with spinal cord injury”, which appeared in Volume 96, Issue 20 of Medicine, has been retracted for plagiarism and academic fraud. Similar design study, language, and tables were found in a previously published article, “Botulinum toxin type A for neuropathic pain in patients with spinal cord injury”, which appeared in Volume 79, Issue 4 of Annals of Neurology, without any attribution or citation.
منابع مشابه
A randomized controlled trial of botulinum toxin A for treating neuropathic pain in patients with spinal cord injury
BACKGROUND To assess the effect of botulinum toxin A (BTA) for treating neuropathic pain in patients with spinal cord injury (SCI). METHODS A total of 44 patients with SCI with neuropathic pain were randomly divided into the intervention group and the placebo group, each group 21 patients. The subjects in the intervention group received BTA (200 U subcutaneous injection, once daily) at the pa...
متن کاملINJECTION OF BOTULINUM TOXIN IN THE TREATMENT OF ACHALASIA: A RANDOMIZED, DOUBLE BLIND, CONTROLLED CLINICAL TRIAL
Our aim was to evaluate the short and long term efficacy of botulinum toxin therapy in Iranian patients with achalasia. In a randomized, double blind trial, 20 patients with achalasia, referring to Imam Khomeini Hospital, received either 80 units of botulinum toxin (BT) or placebo (PL) from 1995 to 1998. Two weeks later, the response to treatment was assessed on the basis of changes in the...
متن کاملAnalgesic Effect of Bumetanide on Neuropathic Pain in Patients With Spinal Cord Injury
Objectives: The current study evaluated the analgesic effects of bumetanide as an adjunctive in the management of neuropathic pain following spinal cord injury (SCI). The peripheral expression of Na-K-Cl cotransporter-1 (NKCC1) and K-Cl cotransporter-2 (KCC2) genes in polymorphonuclear lymphocytes (PMLs) was assessed as a possible biomarker indicating central mechanisms underlying the observed ...
متن کاملEfficacy of venlafaxine XR for the treatment of pain in patients with spinal cord injury and major depression: a randomized, controlled trial.
OBJECTIVES To (1) determine the efficacy of venlafaxine XR for the treatment of pain (secondary aim) in individuals with spinal cord injury (SCI) enrolled in a randomized controlled trial (RCT) on the efficacy of venlafaxine XR for major depressive disorder (MDD) (primary aim); and (2) test the hypothesis that venlafaxine XR would be effective for both neuropathic and nociceptive pain. DESIGN...
متن کاملIntravenous lidocaine relieves spinal cord injury pain: a randomized controlled trial.
BACKGROUND Neuropathic pain in spinal cord injury is a common challenging therapeutic condition. The current study examines the analgesic effect of the sodium channel blocker lidocaine on neuropathic pain in patients with spinal cord injury and the predictive role of concomitant evoked pain on pain relief with lidocaine. METHODS Twenty-four spinal cord injury patients with neuropathic pain at...
متن کامل